Endometriosis – Talk Bio

Mallinckrodt and Endo Announce $6.7 Billion Merger to Create Diversified Pharmaceutical Leader

1 month ago talkbio0Tagged Endo, Endometriosis, generics, Litigation, mallinckrodt, Opioids, Pharmaceutical merger, synergies

Pharmaceutical merger, Mallinckrodt, Endo, opioid litigation, generics, branded drugs, synergies

Pharmaceutical Giants Mallinckrodt and Endo Explore $7 Billion Merger

1 month ago talkbio0Tagged Endo, Endometriosis, mallinckrodt, Medical Specialities, Opioid Crisis, pharmaceutical companies, Pharmaceutical merger, Post-bankruptcy consolidation

Pharmaceutical merger, Mallinckrodt, Endo, $7 billion deal, Specialty pharmaceutical companies, Post-bankruptcy consolidation, Opioid crisis fallout

Breaking the Silence: Endo’s “I Got Somebody” Campaign Encourages Men to Seek Help for Peyronie’s Disease

3 months ago talkbio0Tagged Awareness, campaign, Endometriosis, Hospital specialist, men 's health, nonsurgical treatment options, Peyronie 's disease, Social stigmata, Urology

Peyronie’s disease, men’s health, Endo, “I Got Somebody” campaign, urology specialists, nonsurgical treatment options, disease awareness, stigma reduction.

Endo’s Par Pharmaceutical Recalls Blood Pressure Medication Due to Potential Contamination

12 months ago talkbio0Tagged adulteration, blood pressure medication, Dosage Forms, Endometriosis, Expiration, function, hydrochlorothiazide, Mental Recall, mg/12.5, Tablet Dosage Form

Endo, Par Pharmaceutical, recall, blood pressure medication, contamination, quinapril HCl/ hydrochlorothiazide tablets, USP 20 mg/12.5 mg, lot number 0KG190092, expiration date 03/2022